#VisualAbstract: Pembrolizumab versus Nivolumab–Ipilimumab for Treatment-Naive Advanced Non-Small-Cell Lung Cancer
Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreSep 5, 2024
Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreSep 3, 2024
The following is a summary of “Determinants of successful minimally invasive surgery (MIS) for...
Read MoreSep 2, 2024
The following is a summary of “Real-life nationwide characteristics and outcomes of small cell...
Read MoreAug 31, 2024
The following is a summary of “Differences in Healthcare and Palliative Care Utilization at the...
Read MoreAug 29, 2024
Second primary lung cancers (SPLC) may be more common than previously known, with up to 1 in 6 survivors developing SPLC, but research is limited.
Read MoreAug 24, 2024
Findings in JAMA Oncology suggest intensity-modulated radiotherapy improves outcomes among patients with locally advanced non-small cell lung cancer.
Read MoreAug 21, 2024
The following is a summary of “Risk of Lung Cancer in Rheumatoid Arthritis and Rheumatoid...
Read MoreAug 20, 2024
The following is a summary of “Pilot Intervention to increase uptake of lung cancer...
Read MoreAug 20, 2024
1. In this modeling study, an alternative set of lung cancer screening criteria was more sensitive...
Read MoreAug 20, 2024
MONDAY, Aug. 19, 2024 (HealthDay News) — Simple alternative criteria for lung cancer...
Read MoreAug 15, 2024
Postsurgical outcomes for patients with lung cancer improved with electronic patient-reported outcome-based symptom management compared with usual care.
Read MoreAug 5, 2024
Patients with non-small cell lung cancer (NSCLC) with liver metastasis have a poor prognosis, and there are no reliable biomarkers for predicting disease progression. Currently, no recognized and reliable prediction model exists...
Read MoreAug 2, 2024
The following is a summary of “Associations between dysregulation of human blood metabolites and...
Read MoreAug 2, 2024
THURSDAY, Aug. 1, 2024 (HealthDay News) — People who’ve had a history of smoking can...
Read MoreJul 30, 2024
Cardio-oncology rehabilitation is a critical intervention for lung cancer survivors, particularly those diagnosed at an early stage and under-going lobectomy, as maximal oxygen up-take peak (VO2PEAK) is a strong prognostic...
Read MoreJul 29, 2024
Ex-smokers who used electronic cigarettes had higher risks for lung cancer and lung cancer-specific death than those who did not vape.
Read MoreJul 23, 2024
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreJul 15, 2024
Non-small cell lung cancer (NSCLC) patients with EGFR mutations exhibit an unfavorable response to immune checkpoint inhibitor (ICI) monotherapy, and their tumor microenvironment (TME) is usually immunosuppressed. TGF-β plays an...
Read MoreJul 10, 2024
Electronic cigarette use is associated with a lower use of lung cancer screening (LCS), according...
Read MoreJul 10, 2024
The following is a summary of “Lung Cancer Screening Provider Recommendation and Completion in...
Read MoreSed vitae nulla id ipsum molestie scelerisque vitae vitae ligula. Fusce a massa tortor.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.